By Colin Kellaher


Life-sciences giant Thermo Fisher Scientific has struck a $3.1 billion deal to buy Swedish proteomics company Olink Holding.

Thermo Fisher on Tuesday said it will pay $26 a share in cash for Olink, a nearly 74% premium to Monday's closing price of $14.98.

Thermo Fisher said the acquisition of Olink, which offers solutions for advanced proteomics discovery and development, is highly complementary to its mass-spectrometry and life-sciences platforms.

Thermo Fisher, based in Waltham, Mass., plans to fund the acquisition with cash on hand and debt financing, adding that the deal is slated to close by mid-2024.

Trading in shares of Olink was halted premarket on Tuesday.


Write to Colin Kellaher at colin.kellaher@wsj.com


(END) Dow Jones Newswires

10-17-23 0846ET